These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 34519230)

  • 1. Tailoring thixotropic mixed-lipid nanoconstructs of voriconazole for the management of Vulvovaginal candidiasis: Formulation, statistical optimization,
    Abd-Elsalam WH; Nagy YI; Abouelatta SM
    Drug Deliv; 2021 Dec; 28(1):1877-1889. PubMed ID: 34519230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surface-modified mucoadhesive microgels as a controlled release system for miconazole nitrate to improve localized treatment of vulvovaginal candidiasis.
    Kenechukwu FC; Attama AA; Ibezim EC; Nnamani PO; Umeyor CE; Uronnachi EM; Gugu TH; Momoh MA; Ofokansi KC; Akpa PA
    Eur J Pharm Sci; 2018 Jan; 111():358-375. PubMed ID: 28986195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanolipid Gel of an Antimycotic Drug for Treating Vulvovaginal Candidiasis-Development and Evaluation.
    Takalkar D; Desai N
    AAPS PharmSciTech; 2018 Apr; 19(3):1297-1307. PubMed ID: 29340981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statistical optimization of hyaluronic acid enriched ultradeformable elastosomes for ocular delivery of voriconazole via Box-Behnken design:
    Fahmy AM; Hassan M; El-Setouhy DA; Tayel SA; Al-Mahallawi AM
    Drug Deliv; 2021 Dec; 28(1):77-86. PubMed ID: 33342315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of vulvovaginal candidiasis among pregnant women in the Ho municipality, Ghana: species identification and antifungal susceptibility of Candida isolates.
    Waikhom SD; Afeke I; Kwawu GS; Mbroh HK; Osei GY; Louis B; Deku JG; Kasu ES; Mensah P; Agede CY; Dodoo C; Asiamah EA; Tampuori J; Korbuvi J; Opintan JA
    BMC Pregnancy Childbirth; 2020 May; 20(1):266. PubMed ID: 32375724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amelioration of ketoconazole in lipid nanoparticles for enhanced antifungal activity and bioavailability through oral administration for management of fungal infections.
    Dudhipala N; Ay AA
    Chem Phys Lipids; 2020 Oct; 232():104953. PubMed ID: 32814084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development, optimization, and evaluation of a nanostructured lipid carrier of sesame oil loaded with miconazole for the treatment of oral candidiasis.
    Hosny KM; Sindi AM; Ali S; Alharbi WS; Hajjaj MS; Bukhary HA; Badr MY; Mushtaq RY; Murshid SSA; Almehmady AM; Bakhaidar RB; Alfayez E; Kurakula M
    Drug Deliv; 2022 Dec; 29(1):254-262. PubMed ID: 35014929
    [No Abstract]   [Full Text] [Related]  

  • 8. [INVESTIGATION ON ANTIFUNGAL SUSCEPTIBILITY OF CANDIDA YEASTS IN PREGNANT PATIENTS WITH CONFIRMED VULVOVAGINAL CANDIDIASIS AND THEIR NEWBORNS.].
    Chokoeva A; Kouzmanov A; Ivanova Z; Zisova L; Amalie G; Petleshkova P; Miteva-Katrandzhieva T; Krasteva M; Uchikova E
    Akush Ginekol (Sofiia); 2016; 55(4):20-29. PubMed ID: 29370489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioadhesive vaginal drug delivery of nystatin using a derivatized polymer: Development and characterization.
    Bassi P; Kaur G
    Eur J Pharm Biopharm; 2015 Oct; 96():173-84. PubMed ID: 26235393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formulation, optimization, and nephrotoxicity evaluation of an antifungal in situ nasal gel loaded with voriconazole‒clove oil transferosomal nanoparticles.
    Kammoun AK; Khedr A; Hegazy MA; Almalki AJ; Hosny KM; Abualsunun WA; Murshid SSA; Bakhaidar RB
    Drug Deliv; 2021 Dec; 28(1):2229-2240. PubMed ID: 34668818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Curcumin-Loaded Liquid Crystalline Systems for Controlled Drug Release and Improved Treatment of Vulvovaginal Candidiasis.
    Rodero CF; Fioramonti Calixto GM; Cristina Dos Santos K; Sato MR; Aparecido Dos Santos Ramos M; Miró MS; Rodríguez E; Vigezzi C; Bauab TM; Sotomayor CE; Chorilli M
    Mol Pharm; 2018 Oct; 15(10):4491-4504. PubMed ID: 30184431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Miconazole-loaded solid lipid nanoparticles: formulation and evaluation of a novel formula with high bioavailability and antifungal activity.
    Aljaeid BM; Hosny KM
    Int J Nanomedicine; 2016; 11():441-7. PubMed ID: 26869787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced antifungal activity of voriconazole-loaded nanostructured lipid carriers against
    Tian B; Yan Q; Wang J; Ding C; Sai S
    Int J Nanomedicine; 2017; 12():7131-7141. PubMed ID: 29026306
    [No Abstract]   [Full Text] [Related]  

  • 14. The role of formulation and follicular pathway in voriconazole cutaneous delivery from liposomes and nanostructured lipid carriers.
    Santos GA; Angelo T; Andrade LM; Silva SMM; Magalhães PO; Cunha-Filho M; Gelfuso GM; Taveira SF; Gratieri T
    Colloids Surf B Biointerfaces; 2018 Oct; 170():341-346. PubMed ID: 29940500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymeric micelle gel with luliconazole: in vivo efficacy against cutaneous candidiasis in Wistar rats.
    Singh G; Narang RK
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Sep; 397(9):7001-7015. PubMed ID: 38625553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antifungal activities of two new azasordarins, GW471552 and GW471558, in experimental models of oral and vulvovaginal candidiasis in immunosuppressed rats.
    Martinez A; Ferrer S; Santos I; Jimenez E; Sparrowe J; Regadera J; De Las Heras FG; Gargallo-Viola D
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3304-9. PubMed ID: 11709301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of formulation variables on miconazole nitrate-loaded lipid based nanocarrier for topical delivery.
    Al-Maghrabi PM; Khafagy ES; Ghorab MM; Gad S
    Colloids Surf B Biointerfaces; 2020 Sep; 193():111046. PubMed ID: 32416518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Voriconazole incorporated nanofiber formulations for topical application: preparation, characterization and antifungal activity studies against
    Esentürk İ; Balkan T; Özhan G; Döşler S; Güngör S; Erdal MS; Sarac AS
    Pharm Dev Technol; 2020 Apr; 25(4):440-453. PubMed ID: 31851857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New therapeutic system based on hydrogels for vaginal candidiasis management: formulation-characterization and
    Arpa MD; Yoltaş A; Onay Tarlan E; Şenyüz CŞ; Sipahi H; Aydın A; Üstündağ Okur N
    Pharm Dev Technol; 2020 Dec; 25(10):1238-1248. PubMed ID: 32787718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of thiosemicarbazide free or within chitosan nanoparticles in a murine model of vulvovaginal candidiasis.
    Araújo DE; de Oliveira AA; Cabral MDS; Costa AF; Silva BC; do Carmo Silva L; de Menezes LB; de Almeida Soares CM; Amaral AC; Pereira M
    Braz J Microbiol; 2020 Dec; 51(4):1465-1473. PubMed ID: 32638273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.